Abstract:The gut microbiota is essential for numerous aspects of human health. However, the underlying mechanisms of many host-microbiota interactions remain unclear. The aim of this study was to characterize effects of the microbiota on host epithelium using a novel ex vivo model based on mouse ileal organoids. We have explored the transcriptional response of organoids upon exposure to short-chain fatty acids (SCFAs) and products generated by two abundant microbiota constituents, Akkermansia muciniphila and Faecalibacterium prausnitzii. We observed that A. muciniphila metabolites affect various transcription factors and genes involved in cellular lipid metabolism and growth, supporting previous in vivo findings. Contrastingly, F. prausnitzii products exerted only weak effects on host transcription. Additionally, A. muciniphila and its metabolite propionate modulated expression of Fiaf, Gpr43, histone deacetylases (HDACs), and peroxisome proliferator-activated receptor gamma (Pparγ), important regulators of transcription factor regulation, cell cycle control, lipolysis, and satiety. This work illustrates that specific bacteria and their metabolites differentially modulate epithelial transcription in mouse organoids. We demonstrate that intestinal organoids provide a novel and powerful ex vivo model for host-microbiome interaction studies. Importance: We investigated the influence of the gut microbiota and microbially produced short-chain fatty acids (SCFAs) on gut functioning. Many commensal bacteria in the gut produce SCFAs, particularly butyrate, acetate, and propionate, which have been demonstrated to reduce the risk of gastrointestinal disorders. Organoids-small crypt-villus structures grown from ileal intestinal stem cells-were exposed to SCFAs and two specific gut bacteria. Akkermansia muciniphila, found in the intestinal mucus, was recently shown to have a favorable effect on the disrupted metabolism associated with obesity. Faecalibacterium prausnitzii is a commensal gut bacterium, the absence of which may be associated with Crohn's disease. We showed that in our model, A. muciniphila induces stronger effects on the host than F. prausnitzii. We observed that A. muciniphila and propionate affect the expression of genes involved in host lipid metabolism and epigenetic activation or silencing of gene expression. We demonstrated that organoids provide a powerful tool for host-microbe interaction studies.

Gut Microbiota Has a Widespread and Modifiable Effect on Host Gene Regulation

Interspecies variation in hominid gut microbiota controls host gene regulation

The relationship between the gut microbiome and host gene expression: a review

Epigenetic regulation by gut microbiota

Gut Microbiota as Important Mediator Between Diet and DNA Methylation and Histone Modifications in the Host

A role for gut microbiota in m6A epitranscriptomic mRNA modifications in different host tissues

Unravelling the effects of the environment and host genotype on the gut microbiome

Host genetic control of gut microbiome composition

The Host Shapes the Gut Microbiota Via Fecal MicroRNA.

Dietary metabolites derived from gut microbiota: critical modulators of epigenetic changes in mammals

Symbiotic gut microbes modulate human metabolic phenotypes

Genetic manipulation of gut microbes enables single-gene interrogation in a complex microbiome

Role of gene regulation and inter species interaction as a key factor in gut microbiota adaptation

Gut Microbiota Density Influences Host Physiology and is Shaped by Host and Microbial Factors

Therapeutic modulation of microbiota-host metabolic interactions.

Large-scale association analyses identify host factors influencing human gut microbiome composition

Regulation of microbial gene expression: the key to understanding our gut microbiome

Physiological Role of Gut Microbiota for Maintaining Human Health

Microbial metabolites as modulators of host physiology

Differential modulation by Akkermansia muciniphila and Faecalibacterium prausnitzii of host peripheral lipid metabolism and histone acetylation in mouse gut organoids